UniProt ID | GLUC_HUMAN | |
---|---|---|
UniProt AC | P01275 | |
Protein Name | Glucagon | |
Gene Name | GCG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 180 | |
Subcellular Localization | Secreted. | |
Protein Description | Glucagon plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes.; GLP-1 is a potent stimulator of glucose-dependent insulin release. Play important roles on gastric motility and the suppression of plasma glucagon levels. May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin. Have growth-promoting activities on intestinal epithelium. May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin secretion. Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferation. Inhibits beta cell apoptosis.; GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability.; Oxyntomodulin significantly reduces food intake. Inhibits gastric emptying in humans. Suppression of gastric emptying may lead to increased gastric distension, which may contribute to satiety by causing a sensation of fullness.; Glicentin may modulate gastric acid secretion and the gastro-pyloro-duodenal activity. May play an important role in intestinal mucosal growth in the early period of life.. | |
Protein Sequence | MKSIYFVAGLFVMLVQGSWQRSLQDTEEKSRSFSASQADPLSDPDQMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIAKRHDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGRRDFPEEVAIVEELGRRHADGSFSDEMNTILDNLAARDFINWLIQTKITDRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
26 | Phosphorylation | WQRSLQDTEEKSRSF HHHHCCCHHHHHHCC | 32.84 | - | |
30 | Phosphorylation | LQDTEEKSRSFSASQ CCCHHHHHHCCCHHH | 36.11 | 23312004 | |
32 | Phosphorylation | DTEEKSRSFSASQAD CHHHHHHCCCHHHCC | 30.55 | 23312004 | |
34 | Phosphorylation | EEKSRSFSASQADPL HHHHHCCCHHHCCCC | 28.40 | 26657352 | |
36 | Phosphorylation | KSRSFSASQADPLSD HHHCCCHHHCCCCCC | 25.38 | 26657352 | |
42 | Phosphorylation | ASQADPLSDPDQMNE HHHCCCCCCHHHCCC | 53.11 | 23312004 | |
54 | Phosphorylation | MNEDKRHSQGTFTSD CCCCHHHCCCCCCHH | 34.05 | 25072903 | |
57 | Phosphorylation | DKRHSQGTFTSDYSK CHHHCCCCCCHHHHH | 18.99 | 25072903 | |
59 | Phosphorylation | RHSQGTFTSDYSKYL HHCCCCCCHHHHHHH | 22.11 | 25072903 | |
59 | O-linked_Glycosylation | RHSQGTFTSDYSKYL HHCCCCCCHHHHHHH | 22.11 | OGP | |
60 | Phosphorylation | HSQGTFTSDYSKYLD HCCCCCCHHHHHHHH | 30.29 | 25072903 | |
62 | Phosphorylation | QGTFTSDYSKYLDSR CCCCCHHHHHHHHHH | 13.56 | 23312004 | |
63 | Phosphorylation | GTFTSDYSKYLDSRR CCCCHHHHHHHHHHH | 21.58 | 25072903 | |
68 | Phosphorylation | DYSKYLDSRRAQDFV HHHHHHHHHHHHHHH | 22.52 | - | |
105 | Phosphorylation | HAEGTFTSDVSSYLE HCCCCCCHHHHHHHC | 31.65 | - | |
108 | Phosphorylation | GTFTSDVSSYLEGQA CCCCHHHHHHHCHHH | 20.46 | - | |
127 | Amidation | IAWLVKGRGRRDFPE HHHHHHCCCCCCCCH | 29.72 | 2753890 | |
127 | Arginine amide | IAWLVKGRGRRDFPE HHHHHHCCCCCCCCH | 29.72 | - | |
150 | Phosphorylation | GRRHADGSFSDEMNT HHHCCCCCCCHHHHH | 23.32 | 24670416 | |
152 | Phosphorylation | RHADGSFSDEMNTIL HCCCCCCCHHHHHHH | 34.07 | 24670416 | |
157 | Phosphorylation | SFSDEMNTILDNLAA CCCHHHHHHHHHHHH | 22.93 | 22617229 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GLUC_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GLUC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GLUC_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of GLUC_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...